A cross-practice Ropes & Gray team advised Arrowhead Research Corporation in its acquisition of RNA therapeutics assets from Roche, announced on Oct. 24. As a result of the transaction, Arrowhead will have an array of additional delivery technologies that complement its existing delivery platforms, access to the three primary siRNA formats, and the infrastructure and team necessary to create new RNAi therapeutics and drive large industry partnerships.
The Ropes & Gray team included benefits partner Jonathan Zorn (Boston); and associates Megan Bisk (Boston), Elizabeth Norman (Boston), and Jennifer Rikoski (Boston).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.